Ligand Pharmaceuticals
American Pharmaceutical Company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Ligand Pharmaceuticals, Inc.?
Summarize this article for a 10 year old
Ligand Pharmaceuticals is a biopharmaceutical company located in San Diego, California.[4] Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further.[citation needed]
Company type | Public company |
---|---|
Industry | Biopharmaceuticals |
Founded | September 1987; 36 years ago (1987-09) |
Founder | Brook Byers[1] |
Headquarters | San Diego, California, U.S. |
Key people | John Higgins (CEO) |
Revenue | US$141 million (2017)[2] |
Number of employees | 155 (2020)[3] |
Website | ligand |
The company has been the subject of multiple regulatory investigations,[5] negative shorts-seller reports[6] and class action lawsuits amid allegations of securities fraud.[7][8][9][10]
In 2018 its CEO was listed among the top five highest paid CEOs in San Diego.[11]